Combination Therapy Current Events | Combination Therapy News | 7
|
| Page
7 of
50 |
998 Results |
|
|
|
Sort By:
Page Views | Date |
Researchers find way to make tumor cells easier to destroy
Tumors have a unique vulnerability that can be exploited to make them more sensitive to heat and radiation, researchers at Washington University School of Medicine in St. Louis report. view more (2008-05-07)
UC Davis researchers shed new light on how chemotherapy-induced leukemia develops
Topoisomerase II inhibitors are among the most successful chemotherapy drugs used to treat human cancer. view more (2005-11-16)
New research provides hope for childhood cancer sufferers
Scientists investigating drug therapies for children with Acute Lymphoblastic Leukaemia (ALL) have presented new data demonstrating for the very first time that a small molecule called ABT-737 can increase the effectiveness of standard therapies. view more (2007-07-17)
Prostate cancer vaccines more effective with hormone therapy
Among patients with castration-resistant prostate cancer, the addition of hormone therapy following vaccine treatment improved overall survival compared with either treatment alone or when the vaccine followed hormone treatment, according to recent data published in the July 15 Clinical Cancer Research, a journal of the American Association for... view more... (2008-07-10)
Questions over 'healing effect' of magnet therapy
Patients should be advised that magnet therapy has no proved benefits, and that any healing effect is likely to be small, say US researchers in this week's BMJ. view more (2006-01-06)
Bevacizumab found to improve survival for patients with advanced breast cancer
Inhibiting the growth of blood vessels that supply tumors slows the progression of metastatic breast cancer according to results of a large clinical trial of Avastin, an anti-angiogenic therapy. view more (2007-12-27)
Cetuximab and irinotecan combination increases survival in metastatic colorectal cancer
A phase III trial of 1,298 colorectal cancer patients has found that a combination of the drugs cetuximab (Erbitux) and irinotecan showed a significant improvement in progression-free survival over just irinotecan alone, according to an international team of researchers. view more (2007-04-17)
HRT may prevent endometrial cancer
The long-term use of hormone replacement therapy (HRT) does not increase the risk of endometrial cancer and may even protect the endometrium (the lining of the uterus) from the disease, concludes a study in this week's BMJ. In one of the largest long-term studies of its kind researchers from across the UK collected data from 534 postmenopausal... view more... (2002-07-31)
Jefferson scientists use gene therapy to reverse heart failure in animals
Heart researchers at the Center for Translational Medicine at Jefferson Medical College have used gene therapy to reverse heart failure in animals. view more (2007-05-24)
Baby boomers' boon? LED light and green tea cream to smooth facial wrinkles
Scientists in Germany are reporting a major improvement in their potential new treatment for facial wrinkles that could emerge as an alternative to Botox and cosmetic surgery. view more (2009-09-10)
Study finds BRAF mutations in colorectal cancer cause resistance to anti-EGFR therapy
European researchers have found that metastatic colorectal cancer patients with a mutation in the BRAF gene do not respond to anti-EGFR therapy with cetuximab and panitumumab. view more (2008-10-23)
Study shows combination of immune substances to be safe
New research has shown that the immune-stimulating hormone known as interleukin-12 (IL-12) can safely be administered with interferon, another immune-system protein, as an experimental therapy for some cancers. view more (2005-12-12)
Impaired gene helps nonsmall-cell lung cancer resist drug
Lung cancer cells with a defective version of a potential tumor suppressor gene are highly resistant to attack by a platinum-based drug commonly used to treat the disease. view more (2006-10-02)
Pulmonary hypertension patients improve from combination therapy
For patients with pulmonary arterial hypertension (PAH), adding inhaled iloprost to treatment with bosentan-two different classes of drugs often used individually to treat PAH-increases exercise capability, reduces clinical deterioration and, in some cases, improves diagnostic functional class by one stage. view more (2006-12-01)
Dynamic duo: Combination therapy reverses type 1 diabetes
Researchers have now carefully crafted a combination therapy that reverses recent-onset type 1 diabetes in 2 animal models of disease. view more (2006-04-21)
Combination HDL/LDL therapy has no effect on plaque build-up
For some patients with high cholesterol, even the most aggressive treatment with statin drugs fails to prevent coronary artery disease. Patients with hyperlipidemia - high LDL or "bad" cholesterol and trigylcerides, and low HDL or "good" cholesterol - and those with a family history of high cholesterol are at a high risk for... view more... (2007-03-27)
New therapy prevents dangerous side effect for lymphoma patients
Patients respond well to a new three-drug combination for indolent B cell lymphoma that also spares them prolonged, potentially lethal, suppression of blood production in the bone marrow, researchers at The University of Texas M. D. Anderson Cancer Center report today at the 50th annual meeting of the American Society of Hematology. view more (2008-12-10)
Fewer wrinkles and firmer skin linked to earlier use of estrogen therapy
Long-term hormone estrogen therapy used earlier in menopause is associated with fewer wrinkles and less skin rigidity in postmenopausal women, Yale School of Medicine researchers report in the August issue of Fertility and Sterility. view more (2005-08-29)
Manual therapy is effective treatment for neck pain
Manual therapy is more effective and less costly for treating neck pain than physiotherapy or care by a general practitioner, claim researchers in this week's BMJ. The study involved 183 patients recruited by 42 general practitioners in the Netherlands. All patients were aged 18-70 years and had suffered neck pain for at least two weeks. Sixty... view more... (2003-04-23)
Urologist plays key role in determining use of hormone therapy in prostate cancer
The urologist a patient sees may be a more important factor than the tumor characteristics or the patient's other characteristics in determining the use of hormonal therapy for prostate cancer. view more (2006-06-21)
|
|
| Page
7 of
50 |
998 Results |
|
|
|
Sort By:
Page Views | Date |
|
